J Am Coll Cardiol Intv 2012;5:229 35. 27. Chassin MR, Loeb JM, Schmaltz SP, et al. Accountability measures using measurement to promote quality improvement. N Engl J Med 2010;363:683 8. 28. Bonow RO, Masoudi FA, Rumsfeld JS, et al. ACC/AHA classi - cation of care metrics: performance measures and quality metrics: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. J Am Coll Car- diol 2008;52:2113 7. 29. Grines CL, Bonow RO, Casey DE Jr., et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angi- ography and Interventions, American College of Surgeons, and American Dental Association, with representation from the Amer- ican College of Physicians. J Am Coll Cardiol 2007;49:734 9. 30. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126 30. 31. Melloni C, Peterson ED, Chen AY, et al. Cockcroft-Gault versus modi cation of diet in renal disease: importance of glomerular ltration rate formula for classi cation of chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes. J Am Coll Cardiol 2008;51:991 6. 32. Gurm HS, Dixon SR, Smith DE, et al. Renal function-based contrast dosing to de ne safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 2011;58:907 14. 33. Schweiger MJ, Chambers CE, Davidson CJ, et al. Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures. Catheter Cardiovasc Interv 2007;69:135 40. 34. Stacul F, van der Molen AJ, Reimer P, et al. Contrast induced ne- phropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 2011;21:2527 41. 35. 